Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$83.9K Buy
54,817
+19,255
+54% +$29.3K ﹤0.01% 478
2026
Q1
$64.4K Buy
+35,562
New +$61.5K ﹤0.01% 483
2024
Q4
Sell
-51,227
Closed -$50.8K 408
2024
Q3
$50.8K Buy
51,227
+2,815
+6% +$3.86K ﹤0.01% 350
2024
Q2
$75K Buy
+48,412
New +$75.4K ﹤0.01% 311
2023
Q1
Sell
-129,498
Closed -$168K 349
2022
Q4
$168K Sell
129,498
-3,440
-3% -$5.36K 0.01% 310
2022
Q3
$237K Sell
132,938
-25,946
-16% -$64.6K 0.02% 274
2022
Q2
$361K Buy
158,884
+49,396
+45% +$118K 0.03% 206
2022
Q1
$361K Buy
109,488
+77,234
+239% +$271K 0.01% 163
2021
Q4
$147K Buy
32,254
+8,145
+34% +$61.5K 0.01% 278
2021
Q3
$173K Buy
+24,109
New +$177K 0.01% 239
2021
Q1
$94K Buy
+13,866
New +$92.2K 0.01% 243

Other funds holding OCGN

E Fund Management's OCGN Position: Q2 2026 in Review

E Fund Management increased its Ocugen (OCGN) stake by 54% in Q2 2026, buying an estimated $29.3K and bringing the position to 54,817 shares worth $83.9K. The position accounts for ﹤0.01% of the portfolio, ranked #478.

E Fund Management first reported a position in OCGN in Q1 2021 and has held it in 11 quarters since. The position peaked at $361K in Q2 2022. 148 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • E Fund Management held 54,817 shares of Ocugen worth $83.9K as of Q2 2026.
  • E Fund Management bought 19,255 Ocugen shares in Q2 2026, an estimated $29.3K.
  • Ocugen made up ﹤0.01% of E Fund Management's portfolio in Q2 2026, its #478 holding.
  • E Fund Management first reported a position in Ocugen in Q1 2021 and has held it in 11 quarters since.
  • E Fund Management's Ocugen position peaked at $361K in Q2 2022.
  • 148 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.